Techno Trends - Trending Technology On Pharmaceutical Industry

Insilico Medicine Advances ISM8969 Into Phase 1 Trial as Brain-Penetrant NLRP3 Inhibitor for Neuroinflammation

Yuvraj — Fri, 19 Jun 2026 07:39:02 +0000

Insilico Medicine has reached a significant clinical milestone with the completion of first-in-human dosing of ISM8969 in a Phase 1 study. Conducted in collaboration with Hygtia Therapeutics, the ISM8969 Phase 1 trial marks the transition of this oral, brain-penetrant NLRP3 inflammasome inhibitor from preclinical development into human evaluation. The compound is designed to address chronic […]

The post Insilico Medicine Advances ISM8969 Into Phase 1 Trial as Brain-Penetrant NLRP3 Inhibitor for Neuroinflammation first appeared on World Pharma Today.

IQVIA AI Expands Pharma Reach to NP and PA Prescribers

Yuvraj — Wed, 17 Jun 2026 10:02:06 +0000

IQVIA Digital has introduced new technology designed to help pharmaceutical marketers better identify nurse practitioners (NPs) and physician associates (PAs) who prescribe medicines, using insights obtained from POCN Group, the social and professional community for NPs and PAs that the company acquired in 2024. According to POCN data, NPs and PAs account for 35% of […]

The post IQVIA AI Expands Pharma Reach to NP and PA Prescribers first appeared on World Pharma Today.

Sanofi and Owkin Partner to Co-Develop Agentic AI Tools for Drug Discovery

Yuvraj — Tue, 09 Jun 2026 07:54:12 +0000

Sanofi has entered into a multi-year agreement with France-based agentic AI company Owkin to jointly develop next-generation AI-driven biopharma agents. The partnership includes a five-year licence for Owkin’s K Pro platform, an advanced AI system designed to augment drug discovery and development across pharmaceutical workflows. The two companies have maintained a working relationship since 2021, […]

The post Sanofi and Owkin Partner to Co-Develop Agentic AI Tools for Drug Discovery first appeared on World Pharma Today.

Pfizer and Chai Discovery Sign AI Licensing Deal to Accelerate Drug Discovery

Yuvraj — Sat, 06 Jun 2026 08:04:24 +0000

Pfizer has entered into a licensing agreement with Chai Discovery, granting the pharmaceutical giant access to Chai’s generative AI platform for integration into its drug discovery operations. The deal provides Pfizer with early access to the newly revealed Chai-3 model, as well as a dedicated model trained specifically on Pfizer’s proprietary data and workflows — […]

The post Pfizer and Chai Discovery Sign AI Licensing Deal to Accelerate Drug Discovery first appeared on World Pharma Today.

Sanofi and Snowflake Team Up to Deploy AI-Powered Field Agent Support Tool

Yuvraj — Thu, 04 Jun 2026 08:02:55 +0000

Sanofi has partnered with cloud data platform company Snowflake to develop an artificial intelligence-driven tool designed to assist the pharmaceutical giant’s field sales representatives in their day-to-day operations. The collaboration aims to give Sanofi’s field agents faster, more efficient access to business-critical data and insights while they are out in the field, reducing time spent […]

The post Sanofi and Snowflake Team Up to Deploy AI-Powered Field Agent Support Tool first appeared on World Pharma Today.

Advanced Color Measurement Strengthening Pharma QC

Yuvraj — Tue, 26 May 2026 07:00:49 +0000

Achieving absolute precision in pharmaceutical manufacturing necessitates a comprehensive and rigorous oversight of physical attributes, with color serving as a primary indicator of chemical stability and composition. By integrating sophisticated instrumentation into the laboratory environment, manufacturers can transition from subjective visual assessments to standardized, data-driven methodologies that satisfy the most stringent global regulatory requirements. This strategic focus on color measurement pharma QC facilitates the early identification of raw material impurities and ensures uncompromising batch-to-batch consistency in final dosage forms, thereby bolstering patient safety and brand reputation.

The post Advanced Color Measurement Strengthening Pharma QC first appeared on World Pharma Today.

GMP Compliance in Analytical Testing and Color Control

Yuvraj — Tue, 26 May 2026 06:55:27 +0000

Adhering to Good Manufacturing Practices is a non-negotiable requirement for pharmaceutical organizations dedicated to maintaining global safety and quality standards. The intersection of GMP compliance color control and analytical testing ensures that every step of the production process is meticulously documented, validated, and repeatable. By focusing on the rigorous monitoring of physical attributes and chemical purity, manufacturers can mitigate the risks of contamination and stability failures, delivering high-quality healthcare products that patients and healthcare providers can trust implicitly. This disciplined approach ensures that all quality decisions are based on objective, verifiable data.

The post GMP Compliance in Analytical Testing and Color Control first appeared on World Pharma Today.

Choosing Analytical Instruments for Pharma QC Labs

Yuvraj — Tue, 26 May 2026 06:36:16 +0000

Selecting the right laboratory equipment is a critical decision that directly impacts the efficiency, accuracy, and compliance of pharmaceutical operations. Evaluating analytical instruments pharma QC requirements involves a deep dive into technical specifications, vendor reliability, and the potential for long-term scalability. By choosing tools that integrate seamlessly with existing digital workflows and international regulatory standards, laboratory managers can ensure that their facility is equipped to handle the rigorous demands of modern drug testing and quality assurance. This strategic approach minimizes operational risk and ensures the delivery of safe and effective medications to patients globally.

The post Choosing Analytical Instruments for Pharma QC Labs first appeared on World Pharma Today.

Spectrophotometers Driving Accuracy in Drug Quality

Yuvraj — Tue, 26 May 2026 06:32:57 +0000

Precision in pharmaceutical analysis is fundamental to ensuring that every therapeutic agent delivered to a patient meets the highest safety and efficacy standards. The implementation of high-grade spectrophotometers drug quality control workflows provides a scientific basis for quantifying chemical properties and physical characteristics with unmatched reliability. By leveraging advanced spectral data, manufacturers can validate formulations and detect impurities early in the production cycle, thereby reinforcing the integrity of the global supply chain, ensuring regulatory compliance, and protecting the well-being of patients around the world.

The post Spectrophotometers Driving Accuracy in Drug Quality first appeared on World Pharma Today.

Transforming the Future of Pharmaceutical Innovation

Yuvraj — Mon, 25 May 2026 07:50:34 +0000

The pharmaceutical industry stands at the edge of a technological revolution, one where quantum computing has the potential to redefine how drugs are discovered, developed, and delivered. As the complexity of diseases grows and the demand for faster, more efficient therapies increases, traditional computational methods are reaching their limits. This is where Quantum.Tech World 2026 […]

The post Transforming the Future of Pharmaceutical Innovation first appeared on World Pharma Today.